Literature DB >> 8725098

A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity.

C Smerdou1, I M Anton, J Plana, R Curtiss, L Enjuanes.   

Abstract

Antigenic site D from the spike protein of transmissible gastroenteritis virus (TGEV), which is a continuous epitope critical in neutralization, has been expressed as a fusion protein with E. coli heat-labile toxin B subunit (LT-B) in attenuated S. typhimurium. Synthetic peptides containing the sequence of site D induced TGEV neutralizing antibodies when inoculated subcutaneously in both rabbits and swine. A synthetic oligonucleotide encoding residues 373-398 of TGEV S protein, including antigenic site D, was cloned in frame with the 3' end of LT-B gene, into a plasmid used to transform S. typhimurium delta asd chi 3730. A collection of 6 recombinant plasmids designated pYALTB-D I-VI encoding LTB-site D fusions with a variable number of site D sequences were selected. Four of the 6 LTB-site D fusion products expressed in S. typhimurium chi 3730 formed oligomers (pentamers) that dissociated at > 70 degrees. S. typhimurium chi 3730 (pYALTB-D) V and VI expressed the oligomer forming products with higher antigenicity. Partially purified LTB-site D fusion product expressed from S. typhimurium chi 3730 (pYALTB-D) V induced anti-TGEV neutralizing antibodies in rabbits. Recombinant vaccine strain S. typhimurium delta cya delta crp delta asd chi 3987 transformed with plasmid pYALTB-D V expressed constitutively products that formed oligomers presumably containing 20 copies of site D, and showed a high stability in vitro. This recombinant strain was orally inoculated in rabbits and induced TGEV specific antibodies in both serum and intestinal secretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725098      PMCID: PMC7134069          DOI: 10.1016/0168-1702(95)01265-6

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  27 in total

1.  Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus.

Authors:  W P Posthumus; J A Lenstra; W M Schaaper; A P van Nieuwstadt; L Enjuanes; R H Meloen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Transplantation in miniature swine. I. Fixation of the major histocompatibility complex.

Authors:  D H Sachs; G Leight; J Cone; S Schwarz; L Stuart; S Rosenberg
Journal:  Transplantation       Date:  1976-12       Impact factor: 4.939

3.  CS31A capsule-like antigen as an exposure vector for heterologous antigenic determinants.

Authors:  F Bousquet; C Martin; J P Girardeau; M C Méchin; M Der Vartanian; H Laude; M Contrepois
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

4.  Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein.

Authors:  B Delmas; J Gelfi; H Laude
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

5.  Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic.

Authors:  R Curtiss; S M Kelly
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus.

Authors:  I Correa; F Gebauer; M J Bullido; C Suñé; M F Baay; K A Zwaagstra; W P Posthumus; J A Lenstra; L Enjuanes
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

7.  Antigenic structure of transmissible gastroenteritis virus. I. Properties of monoclonal antibodies directed against virion proteins.

Authors:  H Laude; J M Chapsal; J Gelfi; S Labiau; J Grosclaude
Journal:  J Gen Virol       Date:  1986-01       Impact factor: 3.891

8.  Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.

Authors:  N F Pierce; W C Cray; P F Engel
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

9.  A completely synthetic toxoid vaccine containing Escherichia coli heat-stable toxin and antigenic determinants of the heat-labile toxin B subunit.

Authors:  R A Houghten; R F Engert; J M Ostresh; S R Hoffman; F A Klipstein
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

10.  Antigenic homology among coronaviruses related to transmissible gastroenteritis virus.

Authors:  C M Sánchez; G Jiménez; M D Laviada; I Correa; C Suñé; M j Bullido; F Gebauer; C Smerdou; P Callebaut; J M Escribano
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

View more
  8 in total

1.  Effects of infection with transmissible gastroenteritis virus on concomitant immune responses to dietary and injected antigens.

Authors:  Michael Bailey; Karin Haverson; Bevis Miller; Philip Jones; Isabel Sola; Luis Enjuanes; Christopher R Stokes
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein.

Authors:  Diqiu Liu; Xiangqing Wang; Junwei Ge; Songmei Liu; Yijing Li
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2010-03-11       Impact factor: 2.268

Review 3.  Enteric viral infections of pigs and strategies for induction of mucosal immunity.

Authors:  L J Saif
Journal:  Adv Vet Med       Date:  1999

4.  Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies.

Authors:  I M Antón; S González; M J Bullido; M Corsín; C Risco; J P Langeveld; L Enjuanes
Journal:  Virus Res       Date:  1996-12       Impact factor: 3.303

5.  Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector.

Authors:  H Chen; D M Schifferli
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

6.  Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production.

Authors:  Heng Yang; Sanjie Cao; Xiaobo Huang; Jiawen Liu; Ying Tang; Xintian Wen
Journal:  Vaccine       Date:  2009-06-30       Impact factor: 3.641

7.  Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.

Authors:  Tin-Yun Ho; Shih-Lu Wu; Shin-Ei Cheng; Yen-Chiao Wei; Shan-Ping Huang; Chien-Yun Hsiang
Journal:  Biochem Biophys Res Commun       Date:  2004-01-23       Impact factor: 3.575

Review 8.  Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2020-11-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.